It
may be possible to create a dissolvable cloth that releases
HIV-prevention and pregnancy-prevention drugs. It's hard to believe, but
the condom is still the only way to protect against pregnancy and HIV
at the same time.
But
researchers say they believe they can develop a kind of 21st-century
contraceptive that offers superior protection against pregnancy and
sexually transmitted diseases and that people will like enough to use
consistently. A paper describing early work on the project was published
earlier this month in the journal PLoS One.
The
research team, led by Kim Woodrow at the University of Washington,
received a grant of nearly $1 million last month from the Bill &
Melinda Gates Foundation to pursue the research. The product is an
electrically spun cloth with nanometer-sized fibers that can dissolve to
release drugs, such as medications that prevent pregnancy and HIV
infection. The drug-eluting fibers represent "multipurpose prevention
technology," a method that simultaneously prevents sexually transmitted
infections and unintended pregnancy through a combined physical and
chemical barrier.
"Condoms
and vaginal rings and IUDs have been around for a very long time,"
Cameron Ball, a co-author of the paper and graduate student in
bioengineering, told TakePart. "People would like more options. No one
option will be the silver bullet. The idea is to have multiple options
that people can choose for their lifestyle." Improved methods to protect
against STDs and pregnancy are needed in both developing and developed
countries.
The
spermacide nonoxynol-9 is highly effective at pregnancy prevention but
promotes vaginal inflammation, which then increases the risk of STD
transmission. "What we're hoping to provide is a method of drug delivery
that could be used with a variety of drug compounds," Ball says. "There
are multiple products in the development pipeline to address this need.
These are largely vaginal rings, but vaginal rings are limited in what
they are able to deliver.
They
deliver compounds that are less water soluble. Using fibers allows you
to work with multiple drugs with different properties. You can have
combinations of pharmaceutical agents that you couldn't necessarily have
with a vaginal ring or with a condom." During electrospinning, an
electric field is used to launch a charged fluid jet through the air to
create extremely delicate nanometer-scale fibers that stick to a
collection plate.
(One
nanometer is about one 25-millionth of an inch.) The stretchy fibers
are the platform for delivering medications in the same way that drugs
are delivered through pills or gels. The fibers can also carry larger
molecules, such as proteins and antibodies, that are hard to deliver
through other methods. So far, the team has created a fabric that serves
as a physical barrier to block sperm or to release drugs, such as
contraceptives and antiviral medications.
The
fabric dissolves within minutes, which is considered a benefit because
it offers immediate and discreet protection. But the approach also
allows for controlled release of multiple compounds, Ball says. Last
year, a study aimed at preventing heterosexual HIV transmission using a
gel with the drug tenofovir failed—the likely result of the drug's
strength fading by the time of sex. "If you can have a longer-lasting
gel with nanoparticles, that would be beneficial," Ball says.
"We're
trying to fill a niche in terms of product lifespan." The cloth could
be inserted directly into the body or used as a coating on vaginal rings
or other products, Ball says. While the primary goal of the research is
for products that can be used in places like Africa, where HIV
transmission is especially high, the technology could appeal to a wide
range of societies and cultures.
"You
could have fibers that stay in place for longer or be shaped in the
shape of a diaphragm," he says. "You could include herpes medication.
Herpes prevention is somewhat controversial—it's not clear whether
taking herpes medications prophylactically will help prevent the spread
of the virus. That is another application, potentially."
No comments:
Post a Comment